Search results for " Ly"

showing 10 items of 2487 documents

Effects of Terpenoids from Salvia Willeana in Delayed-type Hypersensitivity, Human Lymphocyte Proliferation and Cytokine Production

2008

The effect of the lipophilic extract of S. willeana and three terpenoids isolated therefrom, camphor, lupeol and oleanolic acid, on oxazolone-induced hypersensitivity was evaluated. The extract reduced the ear edema by 46% at 24 h after challenge. All three terpenoids inhibited the edema and suppressed cytokines release at different rates. Lupeol inhibited the swelling by over 50% and reduced the production of IL-1β by 62%. Camphor caused inhibition of the efferent phase (45% inhibition at 72 h) and the levels of IL-1β, IL-4 and TNF-α (around 80% inhibition). Oleanolic acid diminished moderately the reaction and the levels of IL-4 and TNF-α. We also demonstrated that the three terpenoids i…

PharmacologyHuman lymphocytebiologyChemistrymedicine.medical_treatmentfungiPlant ScienceGeneral MedicinePharmacologySalviabiology.organism_classificationTerpenoidOxazolonechemistry.chemical_compoundCamphorCytokineComplementary and alternative medicineDrug DiscoveryImmunologymedicineOleanolic acidLupeolNatural Product Communications
researchProduct

Indole alkaloids from the coprophilous fungus Aphanoascus fulvescens

2019

Abstract The Ascomycete fungus Aphanoascus fulvescens isolated from goose dung was investigated for its secondary metabolites, yielding five new indole alkaloids okaramines V–Z (1–5) and eleven known derivatives (6–16). Their structures were determined by 1D, 2D NMR spectra and HRMS data. Compounds 6, 8, 11 and 12 showed significant to moderate cytotoxicity against the mouse lymphoma cell line L5178Y with IC50 values ranging from 4.0 to 14.7 μM. Preliminary structure-activity relationships are discussed.

PharmacologyIndole testbiology010405 organic chemistryChemistryStereochemistryMouse LymphomaGeneral MedicineFungusAphanoascus fulvescensbiology.organism_classification01 natural sciences0104 chemical sciences010404 medicinal & biomolecular chemistryGoosebiology.animalDrug DiscoveryIc50 valuesCytotoxicityTwo-dimensional nuclear magnetic resonance spectroscopyFitoterapia
researchProduct

Hla-Bb, Dr3 T Cell Impairhent is Completely Restored by in Vitho Treatment with Interleukin-2

1991

AbstractThe activity of recombinant interleukin-2 (rIL-2) on the in vitro lymphocyte proliferative response to phytohemagglutinin mitogen was investigated in healthy HLA-BB, DR3 positive and negative subjects. the response to mitogen, significantly decreased in HLA-BB, DR3 positive subjects, was completely restored by adding rIL-2. Moreover, in HLA-BB, DR3 positive subjects the in vitro treatment with rIL-2 significantly increased the reduced frequency of mitogen responsive T lymphocyte precursors, as assessed by limiting dilution analysis. These data suggest that a decrease in the size of the pool of T cell precursors able to produce IL-2 is responsible for the impairment of T cell functio…

PharmacologyInterleukin 2medicine.medical_specialtyCell growthmedicine.medical_treatmentT cellLymphocyteImmunologyGeneral MedicineHuman leukocyte antigenT lymphocyteBiologyToxicologymedicine.disease_causeAutoimmunityCytokinemedicine.anatomical_structureEndocrinologyInternal medicineImmunologymedicineImmunology and Allergymedicine.drugImmunopharmacology and Immunotoxicology
researchProduct

Aaptamine Derivatives from the Indonesian Sponge Aaptos suberitoides

2013

Four new aaptamine derivatives (1-4) along with aaptamine (5) and three related compounds (6-8) were isolated from the ethanol extract of the sponge Aaptos suberitoides collected in Indonesia. The structures of the new compounds were unambiguously determined by one- and two-dimensional NMR and by HRESIMS measurements. Compounds 3, 5, and 6 showed cytotoxic activity against the murine lymphoma L5178Y cell line, with IC(50) values ranging from 0.9 to 8.3 μM.

PharmacologyMolecular StructurebiologyMurine lymphomaStereochemistryOrganic ChemistryPharmaceutical ScienceAntineoplastic AgentsAaptos suberitoidesbiology.organism_classificationPoriferaAnalytical ChemistryInhibitory Concentration 50MiceSpongeComplementary and alternative medicineIndonesiaDrug DiscoveryAnimalsHumansMolecular MedicineInhibitory concentration 50Drug Screening Assays AntitumorNaphthyridinesNuclear Magnetic Resonance BiomolecularJournal of Natural Products
researchProduct

Ircinal E, a New Manzamine Derivative from the Indonesian Marine Sponge Acanthostrongylophora ingens

2015

Chemical investigation of the MeOH extract of the sponge Acanthostrongylophora ingens afforded the new manzamine derivative ircinal E (1), in addition to six known metabolites (2–7). The structure of the new compound was unequivocally elucidated using one- and two-dimensional NMR spectroscopy, as well as high-resolution mass spectrometry. Compounds 1–6 exhibited strong to moderate cytotoxicity against the murine lymphoma L5178Y cell line with IC50 values ranging from 2.8 to 21.7 μM.

PharmacologyMurine lymphomabiologyStereochemistryAcanthostrongylophora ingensPlant ScienceGeneral MedicineNuclear magnetic resonance spectroscopybiology.organism_classificationMass spectrometrySpongechemistry.chemical_compoundComplementary and alternative medicinechemistryDrug DiscoveryBotanyMoleculeCytotoxicityDerivative (chemistry)Natural Product Communications
researchProduct

The many faces of erythropoietin: from erythropoiesis to a rational neuroprotective strategy

2008

It has been more than 10 years since the discovery that erythropoietin (EPO) and its receptor are expressed by the nervous system. In that brief time, a remarkable acceleration in understanding the...

PharmacologyNervous systembusiness.industrySettore MED/27 - NeurochirurgiaGeneral MedicineNeuroprotectionRecombinant ProteinsNeuroprotective Agentsmedicine.anatomical_structureErythropoietinhemic and lymphatic diseasesReceptors ErythropoietinmedicineAnimalsHumansErythropoiesisErythropoietin neuroprotectionPharmacology (medical)ReceptorbusinessErythropoietinNeurosciencemedicine.drug
researchProduct

Metabolites from Combretum dolichopetalum and its associated endophytic fungus Nigrospora oryzae--Evidence for a metabolic partnership.

2015

Abstract A new altersolanol derivative, 4-dehydroxyaltersolanol A ( 9 ), along with two known sesquiterpenoids, ( S )-7′-hydroxyabscisic acid ( 7 ) and ( S )-abscisic acid ( 8 ) were obtained from the endophytic fungus, Nigrospora oryzae , isolated from leaves of Combretum dolichopetalum . The host plant yielded six known compounds including ellagic acid ( 1 ), 3, 3′, 4-tri-O-methylellagic acid ( 2 ), arjunolic acid ( 3 ), 4′-dihydrophaseic acid ( 4 ), echinulin ( 5 ) and arestrictin B ( 6 ). Close structural similarities with regard to compounds 4 , 7 and 8 were observed between the metabolites from the host plant and those of the endophytic fungus. Furthermore compounds 5 and 6 are relate…

PharmacologybiologyMolecular StructureStereochemistryMouse LymphomaCombretumAnthraquinonesGeneral MedicineEndophytic fungusbiology.organism_classificationPlant Leaveschemistry.chemical_compoundMicechemistryAscomycotaCell Line TumorDrug DiscoveryEndophytesAnimalsCombretumArestrictin BNigrospora oryzaeCytotoxicityTwo-dimensional nuclear magnetic resonance spectroscopyEllagic acidFitoterapia
researchProduct

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report

2021

Tumour lysis syndrome (TLS) represents a group of fatal metabolic derangements resulting from the rapid breakdown of tumour cells. TLS typically occurs soon after the administration of chemotherapy in haematologic malignancies but is rarely observed in solid tumours. Here, we report a case of brigatinib-induced TLS after treatment with sequential anaplastic lymphoma kinase (ALK) inhibitors in a patient with advanced ALK-rearranged lung adenocarcinoma. The patient was treated sequentially with crizotinib, alectinib, and ensartinib. High-throughput molecular profiling after disease progression indicated that brigatinib may overcome ALK resistance mutations, so the patient was administered bri…

Pharmacologybrigatinibacute kidney injurycase reportPharmacology (medical)Therapeutics. PharmacologyRM1-950targeted therapynon-small cell lung cancertumour lysis syndromeFrontiers in Pharmacology
researchProduct

Aminobisphosphonates as New Weapons for γ δ T Cell-Based Immunotherapy of Cancer

2008

Several observations in mice and in humans have collectively laid the foundation for examining the potential of γ δ T cells to exert tumor immunotherapy. Human γ δ T cells can be activated in a non-MHC dependent fashion either by low molecular mass phosphoantigens, or by agents that provoke the accumulation of endogenous pyrophosphates such as isopentenylpyrophosphate. Among the latter, aminobisphosphonates are well-established in the clinic, and extensive data are available on the compounds antiangiogenic, antiosteolytic and pro-apoptotic properties. In this review we discuss on the possibility that the intentional activation of γ δ T cells in vivo by aminobisphosphonates may represent a p…

Pharmacologybusiness.industrymedicine.medical_treatmentT cellOrganic ChemistryCancerEndogenyImmunotherapyT lymphocytemedicine.diseaseBiochemistrymedicine.anatomical_structureMechanism of actionAntigenIn vivoDrug DiscoveryImmunologymedicineMolecular Medicinemedicine.symptombusinessCurrent Medicinal Chemistry
researchProduct

Profiling the diversity of innate lymphoid cells

2015

Genome-wide transcriptional profiling of tissue-resident innate lymphoid cells (ILCs) has provided important insight not only into their developmental relationships and phenotypic plasticity but also into previously unknown functions.

Phenotypic plasticityImmunologyInnate lymphoid cellImmunology and AllergyProfiling (information science)BiologyCell biologyNature Immunology
researchProduct